About PeriVision
PeriVision is a company based in Epalinges (Switzerland) founded in 2019 by Patrick Kessel. PeriVision has raised $4.69 million across 7 funding rounds from investors including EIT Health, CADFEM and Arya Women. PeriVision offers products and services including VisionOne. PeriVision operates in a competitive market with competitors including Forus Health, Remidio, Optomed, Heru and Identifeye Health, among others.
- Headquarter Epalinges, Switzerland
- Founders Patrick Kessel
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Perivision Sa
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$4.69 M (USD)
in 7 rounds
-
Latest Funding Round
$3 M (USD), Seed
Sep 16, 2025
-
Investors
EIT Health
& 12 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of PeriVision
PeriVision offers a comprehensive portfolio of products and services, including VisionOne.
Enables accurate glaucoma diagnosis through AI-driven VR eye tests.
Funding Insights of PeriVision
PeriVision has successfully raised a total of $4.69M across 7 strategic funding rounds. The most recent funding activity was a Seed round of $3 million completed in September 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in PeriVision
PeriVision has secured backing from 13 investors, including venture fund and institutional investors. Prominent investors backing the company include EIT Health, CADFEM and Arya Women.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
An angel network is facilitated for Swiss-based ICT companies.
|
Locked | Locked | Locked | |
|
Grants and loans are provided by FIT for innovative startups.
|
Locked | Locked | Locked | |
|
Early-stage investments in health and climate tech are made.
|
Locked | Locked | Locked |
Investor details for PeriVision
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by PeriVision
Investment portfolio details for PeriVision
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - PeriVision
Detailed financials for PeriVision
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Perivision Comparisons
Peer comparison for PeriVision
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of PeriVision
PeriVision operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Forus Health, Remidio, Optomed, Heru and Identifeye Health, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Manufacturer of portable digital eye imaging devices and cloud-based healthcare platforms
|
|
| Locked | Locked | Locked |
AI-powered portable solutions for ophthalmic screening and diagnosis are developed.
|
|
| Locked | Locked | Locked |
Provider of handheld fundus cameras and software solutions for eye screening
|
|
| Locked | Locked | Locked |
AI-based wearable devices for vision disorder diagnostics are provided.
|
|
| Locked | Locked | Locked |
Developer of a non-invasive test to detect health conditions through the eyes
|
|
| Locked | Locked | Locked |
Cloud-based vision testing software is offered for the optical industry.
|
Detailed competitors of PeriVision
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Perivision
Complete news archive for PeriVision
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about PeriVision
PeriVision was founded in 2019 and raised its 1st funding round 1 year after it was founded.
PeriVision is headquartered in Epalinges, Switzerland. It is registered at Epalinges, Vaud, Switzerland.
Patrick Kessel is the current CEO of PeriVision. They have also founded this company.
PeriVision is a funded company, having raised a total of $4.69M across 7 funding rounds to date.
SaaS and AI based vision care clinical workflow for professionals and patients. It provides VR visual field testing platform for eye care. It uses virtual reality headsets and cloud computing to diagnose and monitor eye diseases, such as glaucoma. AI algorithms optimize tests, automate assistance, and provide insights for clinical decisions. The technology is validated through clinical studies and published research. The platform facilitates at home vision testing, enhancing patient access and streamlining clinical trials.
PeriVision's top competitors include Remidio, Forus Health and Identifeye Health.
PeriVision offers VisionOne.
PeriVision has 13 investors. Key investors include EIT Health, CADFEM, Arya Women, Founders Network, and Swiss ICT Investor Club.